Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher

Zacks Equity Research

Array BioPharma, Inc. (ARRY) was a big mover last session, as the company saw its shares rise by nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 8.75% in the last 7 days.

The company has seen no estimate revisions in the past 30 days and the Zacks Consensus Estimate has also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Array BioPharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the biotechnology industry include Biogen Idec Inc. (BIIB), Curis, Inc. (CRIS) and Enzo Biochem Inc. (ENZ). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ARRAY BIOPHARMA INC (ARRY): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

CURIS INC (CRIS): Free Stock Analysis Report

ENZO BIOCHEM INC (ENZ): Free Stock Analysis Report

Zacks Investment Research